Summarized by Masters of Longevity from Startupticker.ch.
Geneva medtech received FDA clearance for its MGNTQv0 portable brain MRI, enabling US launch.

Key Takeaways
- MGNTQv0 is cleared for initial authorized clinical use in the US.
- Company is preparing US commercial rollout and assembly scaling in Lowell.
- Ongoing studies and collaborations are continuing to expand device evidence.



